NCOA3 and breast cancer: Despite AIB1 is considered to be only a low penetrant BC modifier, its clinical role could be potentially considerable because the population frequency of AIB1 genotype coding for 28/28 poly-Q repeats is substantially higher (10%) compared to the majority of other low penetrant BC alleles.